Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.
about
Total neoadjuvant therapy for rectal cancer: An emerging option.Trial Watch: Radioimmunotherapy for oncological indications.Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study.The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial
P2860
Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Evaluation of capecitabine and ...... ocally advanced rectal cancer.
@ast
Evaluation of capecitabine and ...... ocally advanced rectal cancer.
@en
type
label
Evaluation of capecitabine and ...... ocally advanced rectal cancer.
@ast
Evaluation of capecitabine and ...... ocally advanced rectal cancer.
@en
prefLabel
Evaluation of capecitabine and ...... ocally advanced rectal cancer.
@ast
Evaluation of capecitabine and ...... ocally advanced rectal cancer.
@en
P2093
P2860
P356
P1476
Evaluation of capecitabine and ...... ocally advanced rectal cancer.
@en
P2093
Guo-Chen Liu
Jing-Hua Tang
Jun-Zhong Lin
Ling-Heng Kong
Mu-Yan Cai
Pei-Rong Ding
Wei-Jiang Sun
Xiao-Jun Wu
P2860
P304
P356
10.1002/JSO.23516
P50
P577
2013-11-28T00:00:00Z